Pulmonary Hypertension Community Call — April

24 April 2026

PVRI's monthly PH Community Calls are free online, informal discussions on the latest developments in PH.

In this PH Community Call, we discussed:

C–C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator by Yoshihide Mitani
Deep-learning networks accurately detect pulmonary hypertension in patients with idiopathic pulmonary fibrosis by Alexandra Arvanitaki, Laura Price, John Wort and Gerhard Diller.
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension by Juan Delgado-San Martin and Allan Lawrie

This webinar was ran live 23 April 2026.

Yoshihide Mitani, Mie University

Alexandra Arvanitaki, Royal Brompton and Harefield hospitals

John Wort, Royal Brompton and Harefield hospitals

Juan Delgado-San Martin, Imperial College London

Allan Lawrie, Imperial College London

Joel James, Community Call Host

Tatiana Kudryashova, Community Call Host

Katarina Zeder, University of Maryland

Rodolfo Estrada, UT San Antonio

Katrina Barry, Community Call Host

Other materials on this topic

21 April 2026

Sex Matters: Translational Advances in Respiratory and PAH Research

The first, Women's Health Task Force, webinar of 2026, exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.

IDDI Workstream or Task Force Learning

2 April 2026

Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension

Pediatric idiopathic pulmonary arterial hypertension (IPAH) refractory to maximal medical therapy is associated with high morbidity and mortality, and therapeutic options remain limited.

Pulmonary Circulation

20 March 2026

Pulmonary Hypertension Community Call — March

In this PH Community Call, we discussed:

Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension
Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia
Acute Hemodynamic Effects of Sotatercept

Community Calls

16 March 2026

Scimitar Syndrome and Pulmonary Hypertension in Pediatric Population: A Retrospective Analysis of the Prevalence, Clinical Characteristics, Risk Factors, and Outcomes

Pulmonary hypertension is a known complication of scimitar syndrome; however, its risk factors and outcomes are not well understood. This study aimed to assess the prevalence, clinical features, risk factors, and outcomes of pulmonary hypertension in patients with scimitar syndrome.

Pulmonary Circulation

Pulmonary Hypertension Community Call — April

Our speakers

Our hosts

Sex Matters: Translational Advances in Respiratory and PAH Research

Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension

Pulmonary Hypertension Community Call — March

Scimitar Syndrome and Pulmonary Hypertension in Pediatric Population: A Retrospective Analysis of the Prevalence, Clinical Characteristics, Risk Factors, and Outcomes

More from PVRI Community Calls